Making Treatments Accessible: A Policy Paper on Determining Appropriate Pricing for Brand-name Pharmaceutical Treatments for HIV/AIDS in Canada/Vers un meilleur acc

This position paper examines public policy related to pharmaceutical drug pricing in Canada and argues that pharmaceutical drugs related to HIV/AIDS treatments can be made more accessible by amending the Patent Act, amending the Patented Medicines Regulations, and amending the practices of the Patented Medicines Price Review Board. The paper includes a history of pharmaceutical patent protection in Canada, an analysis of the impacts of expanded patent protection in Canada, stakeholders' roles in drug pricing, and a number of recommendations for restraining the cost of drugs.